Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada

被引:13
|
作者
Lucas, Philippe [1 ,2 ,3 ]
Boyd, Susan [4 ]
Milloy, M. -J [5 ,6 ]
Walsh, Zach [7 ,8 ]
机构
[1] Univ Victoria, Social Dimens Hlth, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada
[2] Tilray, 1100 Maughan Rd, Nanaimo, BC V9X 1J2, Canada
[3] Canadian Inst Subst Use Res, 2300 McKenzie Ave, Victoria, BC V8N 5M8, Canada
[4] Univ Victoria, Sch Publ Hlth & Social Policy, Fac Human & Social Dev, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada
[5] Univ British Columbia, St Pauls Hosp, Fac Med, 806-1081 Burrard St, Vancouver, BC, Canada
[6] British Columbia Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada
[7] Univ British Columbia, Dept Psychol, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada
[8] Univ British Columbia, Ctr Adv Psychol Sci & Law, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada
关键词
Cannabis; Alcohol; Substitution; Harm reduction; USE DISORDERS; PSYCHIATRIC-DISORDERS; MARIJUANA USE; SUBSTANCE USE; MENTAL-HEALTH; CHRONIC PAIN; DRUG-USE; SUBSTITUTE; PRESCRIPTION; SMOKING;
D O I
10.1016/j.drugpo.2020.102963
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Evidence details how cannabis can influence the use of other psychoactive substances, including prescription medications, alcohol, tobacco and illicit drugs, but very little research has examined the factors associated with these changes in substance use patterns. This paper explores the self-reported use of cannabis as a substitute for alcohol among a Canadian medical cannabis patient population. Methods: Data was derived from a survey of 2102 people enrolled in the Canadian medical cannabis program. We included 973 (44%) respondents who reported using alcohol on at least 10 occasions over a 12 month period prior to initiating medical cannabis, and then used retrospective data on the frequency and amount of alcohol use pre-and post medical cannabis initiation to determine which participant characteristics and other variables were associated with reductions and/or cessation of alcohol use. Results: Overall, 419 (44%) participants reported decreases in alcohol usage frequency over 30 days, 323 (34%) decreased the number of standard drinks they had per week, and 76 (8%) reported no alcohol use at all in the 30 days prior to the survey. Being below 55 years of age and reporting higher rates of alcohol use in the pre-period were both associated with greater odds of reducing alcohol use, and an intention to use medical cannabis to reduce alcohol consumption was associated with significantly greater odds of both reducing and ceasing alcohol use altogether. Conclusions: Our findings suggest that medical cannabis initiation may be associated with self-reported reductions and cessation of alcohol use among medical cannabis patients. Since alcohol is the most prevalent recreational substance in North America, and its use results in significant rates of criminality, morbidity and mortality, these findings may result in improved health outcomes for medical cannabis patients, as well as overall improvements in public health and safety.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada
    Lucas, Philippe
    Walsh, Zach
    Hendricks, Peter S.
    Boyd, Susan
    Milloy, M. -J.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130
  • [2] Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study
    Fitzcharles, M-A
    Rampakakis, E.
    Sampalis, J.
    Shir, Y.
    Cohen, M.
    Starr, M.
    Hauser, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : S115 - S119
  • [3] Use of Medical Cannabis by Patients with Fibromyalgia: A Prospective Cross-sectional Study
    Fitzcharles, Mary-Ann
    Rampakakis, Emmanouil
    Shir, Yoram
    Sampalis, John
    Cohen, Martin
    Starr, Michael
    Haeuser, Winfried
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
    Sexton, Michelle
    Cuttler, Carrie
    Finnell, John S.
    Mischley, Laurie K.
    CANNABIS AND CANNABINOID RESEARCH, 2016, 1 (01) : 131 - 138
  • [5] Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients
    Lucas, Philippe
    Baron, Eric P.
    Jikomes, Nick
    HARM REDUCTION JOURNAL, 2019, 16 (1)
  • [6] Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients
    Philippe Lucas
    Eric P. Baron
    Nick Jikomes
    Harm Reduction Journal, 16
  • [7] A cross-sectional survey of cannabis use by people with MS in Oregon and Washington, states where cannabis is legal for medical and recreational use
    Rice, J.
    Hildebrand, A.
    Spain, R.
    Senders, A.
    Silbermann, E.
    Wooliscroft, L.
    Yadav, V.
    Hugos, C.
    Cameron, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 394 - 395
  • [8] Concurrent Use of Prescription Benzodiazepines and Cannabis in Prevalent Medical Cannabis Users with Mental Health Conditions: A Cross-Sectional Survey
    Goodin, Amie
    Bae, Jungjun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 435 - 436
  • [9] Simultaneous Cannabis and Alcohol Use among Medical Cannabis Patients
    Kritikos, Alexandra F.
    Johnson, Julie K.
    Hodgkin, Dominic
    SUBSTANCE USE & MISUSE, 2024, 59 (06) : 847 - 857
  • [10] Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
    Suraev, Anastasia
    Mills, Llewellyn
    Abelev, Sarah, V
    Arkell, Thomas R.
    Lintzeris, Nicholas
    McGregor, Iain S.
    NATURE AND SCIENCE OF SLEEP, 2023, 15 : 245 - 255